Fulcrum Therapeutics Earning Date (FULC)

USA |NASDAQ |USD

FULC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 $-0.63 - $-0.60
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 $3.95M - $4.38M

Fulcrum Therapeutics's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

FULC Earnings Date & History Chart

FULC Earnings & Revenue Forecast

FULC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 7 $-0.63 $-0.67 $-0.56
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $-2.52 $-3.10 $-2.06
Dec 2023 8 $-2.69 $-3.35 $-1.86

FULC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $-0.65 $-0.62 $-0.62
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 4 / 0 $-2.72 $-2.66 $-2.56
Dec 2023 2 / 0 $-2.89 $-2.99 $-2.73

FULC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 7 $3.95M $2.00M $5.16M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $14.25M $0.00 $20.74M
Dec 2023 8 $14.18M $0.00 $20.95M

FULC Earnings Date & Revenue History

FULC Earnings History

|
Show More
Show More

FULC Revenue History

|
Show More
Show More

Fulcrum Therapeutics Next Earnings Date & Report

FULC Next Earnings Date & Report Preview: Jun 2022 (FQ)

FULC's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Fulcrum Therapeutics's next quarterly earnings is $-0.63, with a low EPS estimation of $-0.67, and a high estimation of $-0.56.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.65, the last 2 month trend is $-0.62, and the 3 month trend is $-0.62.

Based on analysts, the average revenue estimation is $3.95M, with a low revenue estimation of $2.00M, and a high estimation of $5.16M.

Fulcrum Therapeutics Previous Earnings Dates & Reports

FULC Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Fulcrum Therapeutics's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

FULC Previous Earnings Date & Report Recap: Dec 2021 (FY)

Fulcrum Therapeutics's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.

FULC's earnings per share (EPS) was $-2.29, beating the consensus analysts forecast of $-2.38 by -3.78% , and higher than the previous year's EPS (Dec 2020) by -18.21%.

Revenues were $19.16M, better than the forecast of $14.39M by 33.17%, and up by 117.19% from previous year's revenue.

The company reported a net income of $-80.85M.

Fulcrum Therapeutics reported a free cash flow of $-80.19M for its fiscal year, compared to $-55.00M a year ago.

The company ended the fiscal year with $469.00K in total debt, an increase of 2658.82% compared to the previous year.